
Sakar Healthcare Limited – NSE:SAKAR.NS
Sakar Healthcare Limited stock price today
Sakar Healthcare Limited stock price monthly change
Sakar Healthcare Limited stock price quarterly change
Sakar Healthcare Limited stock price yearly change
Sakar Healthcare Limited key metrics
Market Cap | 6.57B |
Enterprise value | 5.15B |
P/E | 0.24 |
EV/Sales | 3.98 |
EV/EBITDA | 13.49 |
Price/Sales | 3.19 |
Price/Book | 2.66 |
PEG ratio | N/A |
EPS | 5.54 |
Revenue | 1.53B |
EBITDA | 405.41M |
Income | 116.70M |
Revenue Q/Q | 5.92% |
Revenue Y/Y | 14.99% |
Profit margin | 13.75% |
Oper. margin | 15.34% |
Gross margin | 44.83% |
EBIT margin | 15.34% |
EBITDA margin | 26.44% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSakar Healthcare Limited stock price history
Sakar Healthcare Limited stock forecast
Sakar Healthcare Limited financial statements
Jun 2023 | 389.88M | 28.40M | 7.28% |
---|---|---|---|
Sep 2023 | 340.78M | 36.35M | 10.67% |
Dec 2023 | 372.25M | 20.74M | 5.57% |
Mar 2024 | 430.58M | 31.20M | 7.25% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 3573484000 | 1.20B | 33.7% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 3886591000 | 1.26B | 32.5% |
Jun 2023 | 90.37M | 0 | 0 |
---|---|---|---|
Sep 2023 | 84.43M | 0 | 0 |
Dec 2023 | 88.89M | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Sakar Healthcare Limited alternative data
Aug 2023 | 297 |
---|---|
Sep 2023 | 297 |
Oct 2023 | 297 |
Nov 2023 | 297 |
Dec 2023 | 297 |
Jan 2024 | 297 |
Feb 2024 | 297 |
Mar 2024 | 297 |
Apr 2024 | 297 |
May 2024 | 297 |
Jun 2024 | 297 |
Jul 2024 | 297 |
Sakar Healthcare Limited other data
Insider | Compensation |
---|---|
Mr. Jhonny George Kudilil (1961) Chief Financial Officer | $582,000 |
-
What's the price of Sakar Healthcare Limited stock today?
One share of Sakar Healthcare Limited stock can currently be purchased for approximately $159.55.
-
When is Sakar Healthcare Limited's next earnings date?
Unfortunately, Sakar Healthcare Limited's (SAKAR.NS) next earnings date is currently unknown.
-
Does Sakar Healthcare Limited pay dividends?
No, Sakar Healthcare Limited does not pay dividends.
-
How much money does Sakar Healthcare Limited make?
Sakar Healthcare Limited has a market capitalization of 6.57B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20.23% to 1.54B US dollars.
-
What is Sakar Healthcare Limited's stock symbol?
Sakar Healthcare Limited is traded on the NSE under the ticker symbol "SAKAR.NS".
-
What is Sakar Healthcare Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Sakar Healthcare Limited?
Shares of Sakar Healthcare Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sakar Healthcare Limited's key executives?
Sakar Healthcare Limited's management team includes the following people:
- Mr. Jhonny George Kudilil Chief Financial Officer(age: 64, pay: $582,000)
-
How many employees does Sakar Healthcare Limited have?
As Jul 2024, Sakar Healthcare Limited employs 297 workers.
-
When Sakar Healthcare Limited went public?
Sakar Healthcare Limited is publicly traded company for more then 8 years since IPO on 16 Mar 2017.
-
What is Sakar Healthcare Limited's official website?
The official website for Sakar Healthcare Limited is sakarhealthcare.com.
-
How can i contact Sakar Healthcare Limited?
Sakar Healthcare Limited can be reached via phone at +91 79 2658 4655.
Sakar Healthcare Limited company profile:

Sakar Healthcare Limited
sakarhealthcare.comNSE
325
Drug Manufacturers - Specialty & Generic
Healthcare
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Ahmedabad, 380007
:
ISIN: INE732S01012
CUSIP: Y7455Q100